This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,570 Years Active: 2001
Title: Karel Ulbrich: Innovator in Nucleic Acid Delivery Systems
Introduction
Karel Ulbrich is a prominent inventor based in Prague, Czech Republic. He has made significant contributions to the field of gene therapy through his innovative work on synthetic polymer-based carrier vehicles for the delivery of nucleic acid materials. His research focuses on enhancing the effectiveness of gene therapy by improving the delivery mechanisms of nucleic acids to target cells.
Latest Patents
Karel Ulbrich holds a patent for the "Delivery of nucleic acid materials." This patent describes a method involving the self-assembly of nucleic acids with cationic polymer materials. The process condenses the nucleic acid to form a polyelectrolyte complex, which is then reacted with hydrophilic polymer materials. This reaction results in a hydrophilic coating that stabilizes the complex and provides an outer protective steric shield. These carrier vehicles are particularly useful for applications in gene therapy, showcasing Ulbrich's commitment to advancing medical science.
Career Highlights
Throughout his career, Karel Ulbrich has focused on the intersection of polymer chemistry and biotechnology. His innovative approaches have led to advancements in the delivery systems used in gene therapy, making significant impacts in the field. His work is recognized for its potential to improve therapeutic outcomes for patients requiring gene-based treatments.
Collaborations
Karel Ulbrich has collaborated with notable professionals in his field, including Etienne Honore Schacht and Leonard C W Seymour. These collaborations have further enriched his research and contributed to the development of effective nucleic acid delivery systems.
Conclusion
Karel Ulbrich's contributions to the field of gene therapy through his innovative patent on nucleic acid delivery systems highlight his role as a leading inventor. His work continues to pave the way for advancements in medical treatments, demonstrating the importance of innovation in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile